JOINT FILING AGREEMENTJoint Filing Agreement • October 5th, 2021 • Schuler Jack W • Laboratory analytical instruments
In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, each of the undersigned parties hereby agrees to file jointly Amendment No. 9 to Schedule 13D (including any amendments thereto) (the “Statement”) with respect to the common stock, $0.001 per share par value (the “Common Stock”), of Accelerate Diagnostics, Inc., a Delaware corporation.
